Rhea M Shields
Examiner (ID: 2487, Phone: (571)272-3848 , Office: P/2915 )
Most Active Art Unit | 2915 |
Art Unit(s) | 2915 |
Total Applications | 3243 |
Issued Applications | 2995 |
Pending Applications | 31 |
Abandoned Applications | 206 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6633736
[patent_doc_number] => 20100311950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'SOY PROTEIN GEL AND METHOD OF PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/734547
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12542
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311950.pdf
[firstpage_image] =>[orig_patent_app_number] => 12734547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734547 | Soy protein gel and method of producing the same | Oct 5, 2008 | Issued |
Array
(
[id] => 5379742
[patent_doc_number] => 20090191581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'CELL-PERMEABLE FLUORESCENT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/245546
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7368
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191581.pdf
[firstpage_image] =>[orig_patent_app_number] => 12245546
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/245546 | Cell-permeable fluorescent proteins | Oct 2, 2008 | Issued |
Array
(
[id] => 4629161
[patent_doc_number] => 08008044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Animal product free media and processes for obtaining a botulinum toxin'
[patent_app_type] => utility
[patent_app_number] => 12/234537
[patent_app_country] => US
[patent_app_date] => 2008-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10189
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008044.pdf
[firstpage_image] =>[orig_patent_app_number] => 12234537
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/234537 | Animal product free media and processes for obtaining a botulinum toxin | Sep 18, 2008 | Issued |
Array
(
[id] => 8834345
[patent_doc_number] => 08450100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Collagen peptide having immune-enhancing activity from Cyanea nozakii and preparation method and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/993819
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2967
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993819
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993819 | Collagen peptide having immune-enhancing activity from Cyanea nozakii and preparation method and uses thereof | Sep 16, 2008 | Issued |
Array
(
[id] => 5429144
[patent_doc_number] => 20090088454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'ANTI-CANCER COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/212604
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7281
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088454.pdf
[firstpage_image] =>[orig_patent_app_number] => 12212604
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/212604 | Anti-cancer compounds | Sep 16, 2008 | Issued |
Array
(
[id] => 5416912
[patent_doc_number] => 20090042799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'CLOSTRIDIAL TOXIN DERIVATIVES AND METHODS FOR TREATING PAIN'
[patent_app_type] => utility
[patent_app_number] => 12/211594
[patent_app_country] => US
[patent_app_date] => 2008-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13135
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042799.pdf
[firstpage_image] =>[orig_patent_app_number] => 12211594
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/211594 | Clostridial toxin derivatives and methods for treating pain | Sep 15, 2008 | Issued |
Array
(
[id] => 8725528
[patent_doc_number] => 08404644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-26
[patent_title] => 'Agents with angiogenic and wound healing activity'
[patent_app_type] => utility
[patent_app_number] => 12/676295
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 23673
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12676295
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676295 | Agents with angiogenic and wound healing activity | Sep 4, 2008 | Issued |
Array
(
[id] => 5337838
[patent_doc_number] => 20090054302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Methods and Preparations For Curing Clinically Ill Patients'
[patent_app_type] => utility
[patent_app_number] => 12/196447
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11923
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054302.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196447 | Methods and Preparations For Curing Clinically Ill Patients | Aug 21, 2008 | Abandoned |
Array
(
[id] => 5522201
[patent_doc_number] => 20090030182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'ACTIVATABLE RECOMBINANT NEUROTOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/196658
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15886
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030182.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196658
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196658 | Activatable recombinant neurotoxins | Aug 21, 2008 | Issued |
Array
(
[id] => 7773623
[patent_doc_number] => 08119370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Activatable recombinant neurotoxins'
[patent_app_type] => utility
[patent_app_number] => 12/196381
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 22
[patent_no_of_words] => 15898
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119370.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196381 | Activatable recombinant neurotoxins | Aug 21, 2008 | Issued |
Array
(
[id] => 5522207
[patent_doc_number] => 20090030188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'ACTIVATABLE RECOMBINANT NEUROTOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/195985
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15891
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030188.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195985 | ACTIVATABLE RECOMBINANT NEUROTOXINS | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5539162
[patent_doc_number] => 20090220967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Systemic Carnitine Deficiency Gene and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/193654
[patent_app_country] => US
[patent_app_date] => 2008-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7279
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220967.pdf
[firstpage_image] =>[orig_patent_app_number] => 12193654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/193654 | Systemic Carnitine Deficiency Gene and Uses Thereof | Aug 17, 2008 | Abandoned |
Array
(
[id] => 5508523
[patent_doc_number] => 20090081730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'ACTIVATABLE RECOMBINANT NEUROTOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/193527
[patent_app_country] => US
[patent_app_date] => 2008-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16673
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081730.pdf
[firstpage_image] =>[orig_patent_app_number] => 12193527
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/193527 | Activatable recombinant neurotoxins | Aug 17, 2008 | Issued |
Array
(
[id] => 6472507
[patent_doc_number] => 20100041098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'MODIFIED CLOSTRIDIAL TOXINS WITH ALTERED TARGETING CAPABILITIES FOR CLOSTRIDIAL TOXIN TARGET CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/192934
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 119232
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041098.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192934
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192934 | Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells | Aug 14, 2008 | Issued |
Array
(
[id] => 5349952
[patent_doc_number] => 20090005313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'ACTIVATABLE CLOSTRIDIAL TOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/192419
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 100957
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005313.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192419
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192419 | ACTIVATABLE CLOSTRIDIAL TOXINS | Aug 14, 2008 | Abandoned |
Array
(
[id] => 5310800
[patent_doc_number] => 20090018081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'ACTIVATABLE CLOSTRIDIAL TOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/192854
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 96787
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018081.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192854
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192854 | ACTIVATABLE CLOSTRIDIAL TOXINS | Aug 14, 2008 | Abandoned |
Array
(
[id] => 5291171
[patent_doc_number] => 20090023901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Degradable Clostridial Toxins'
[patent_app_type] => utility
[patent_app_number] => 12/192905
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 63553
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023901.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192905 | Degradable clostridial toxins | Aug 14, 2008 | Issued |
Array
(
[id] => 8409964
[patent_doc_number] => 08273358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-25
[patent_title] => 'Activatable clostridial toxins'
[patent_app_type] => utility
[patent_app_number] => 12/192900
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 33
[patent_no_of_words] => 75469
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12192900
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192900 | Activatable clostridial toxins | Aug 14, 2008 | Issued |
Array
(
[id] => 7976727
[patent_doc_number] => 08071110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Activatable clostridial toxins'
[patent_app_type] => utility
[patent_app_number] => 12/192546
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 33
[patent_no_of_words] => 86496
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071110.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192546
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192546 | Activatable clostridial toxins | Aug 14, 2008 | Issued |
Array
(
[id] => 5348816
[patent_doc_number] => 20090004177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Combination Treatment with t-PA Variant and Low Molecular Weight Heparin'
[patent_app_type] => utility
[patent_app_number] => 12/185588
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11261
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004177.pdf
[firstpage_image] =>[orig_patent_app_number] => 12185588
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/185588 | Combination Treatment with t-PA Variant and Low Molecular Weight Heparin | Aug 3, 2008 | Abandoned |